CoQ10 vs Serrapeptase
A side-by-side research comparison of CoQ10 and Serrapeptase across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | CoQ10 | Serrapeptase |
|---|---|---|
| Full name | Coenzyme Q10 (Ubiquinol) | Serrapeptase (Serratiopeptidase) |
| Category | Cardiovascular | Cardiovascular |
| Status | Dietary supplement | Dietary supplement |
| Mechanism | Shuttles electrons in the mitochondrial respiratory chain (Complex I→III). As ubiquinol, neutralizes lipid peroxyl radicals protecting cell membranes and LDL from oxidation. Restores mitochondrial membrane potential. | Degrades non-living tissue including fibrin, blood clots, mucus, and arterial plaque without harming living cells. Inhibits bradykinin release and reduces prostaglandin synthesis for anti-inflammatory effects. |
| Molecular weight | 863.34 Da | ~52,000 Da |
| Half-life | ~33 hours (ubiquinol) | ~4-6 hours |
| Bioavailability | ~6-9% (standard); ~300% improved with ubiquinol/lipid formulations | Oral (enteric-coated required); detectable in bloodstream |
| Typical dose | 100-300 mg ubiquinol | 120,000-240,000 SPU |
| Frequency | Daily with fat-containing meal | Daily on empty stomach |
| Route | Oral softgel | Oral (enteric-coated) |
CoQ10 reported benefits
- Mitochondrial energy production
- Cardiac function support
- Antioxidant protection
- Statin side effect mitigation
- Exercise performance
- Fertility support (egg/sperm quality)
Serrapeptase reported benefits
- Reduced inflammation and swelling
- Arterial plaque modulation
- Mucus/biofilm breakdown
- Post-surgical recovery
- Sinus/respiratory clearing
- Pain reduction
Related comparisons
Research and educational reference only. Not medical advice.